Volume 20

Clinical Value of Combined CRP and PCT Testing in Differentiating Bacterial from Viral Infections Xiaolei Ge1, Yating Cui1,*. 1, Baoji People’s Hospital, Baoji City, Shaanxi Province, 721000, China. cuiyatingdoudou18@163.com The First Author: Xiaolei Ge, email: 13759784079@163.com ORCID: 0009-0000-8961-6677 Corresponding Author: Yating Cui, email: cuiyatingdoudou18@163.com ORCID: 0009-0003-5488-8201 Acknowledgement:  No Fund Project Abstract Background: Differentiating between viral and bacterial illnesses is essential for efficient clinical therapy and minimizing drug abuse. Aim: This study evaluates the clinical value of Procalcitonin (PCT) and C-reactive proteins (CRP) testing used to identify unique bacterial and viral Acute Respiratory Diseases (ARDs) infections. Methodology:142 children with verified bacterium illness were classed as group I, whereas 78 children with a viral illness were classified as group II. Both groups’ PCT and CRP values were clinically identified and comparatively analyzed. The clinical tests used to identify biomarkers of the PCT and CRP are the Electrochemiluminescence Immunoassay (ECLIA) for PCT biomarkers and the latex Immunoturbidimetry test for CRP biomarkers.  The ANOVA and t-test are used to compare the levels of PCT and CRP, Chi-Square is used to compare the optimistic rate of mutual recognition of PCT and CRP biomarkers, and ROC curve analysis of the diagnostic accuracy of each marker, the comparative analysis stimulated by the SPSS v24. Result: The results showed that PCT levels were significantly considerably greater in group I compared to group II, but there was not a significant distinction in PCT and CRP levels between the groups with and without Gram-positive infections. Conclusion: PCT and CRP serve as helpful indicators to identify acute bacterial and viral illnesses in children. Combining these markers enhances diagnostic accuracy, making them a valuable tool in clinical settings. Keywords: Viral Infections, Bacterial Infections, Acute Respiratory Diseases (ARDs), ANOVA, Clinical test and Biomarkers. In clinical practice, distinguishing between viral and bacterial infections continues to be one of the most important problems since it directly affects treatment choices and patient outcomes. It has been implied that the inability to find ideal criteria for making such distinctions means that clinical judgment must be relied upon which is often incorrect and subjected to errors. As a result, this ambiguity has contributed to the inappropriate use of antibiotics thus promoting resistance while unnecessarily exposing patients to drug side effects [2]. This Venn diagram distinguishes between bacteria and viruses, illustrating typical examples for each. On one side are listed types of bacteria like Spirilla, Micrococci, Bacillus, and Streptococci whereas on the other side viruses such as HIV, Adenovirus, Bacteriophage, and Ebola virus are shown in Figure 1. Figure 1: Familiar Bacteria and virus agents  Various diagnostic tools and biomarkers are used to identify specific types of infections accurately. Supporting diagnostic accuracy are some key biomarkers such as CRP and PCT [3]. CRP level is used as a significant marker for acute inflammatory responses whose levels may rise significantly between 6 – 12 hours after an inflammatory stimulus because it is always synthesized by the liver in response to inflammation [4]. Although both bacterial and viral infections present with elevated levels of CRP they differ in degree of elevation as well as rate of change thus giving insights into what type of infection it is likely going to be [5]. Usually, CRP levels are seen to be higher in cases of infection resulting from bacteria in contrast to those associated with viruses although it is not an absolute rule. PCT is the precursor of calcitonin hormone which is synthesized by thyroid C cells [6]. During severe systemic bacterial infections such as sepsis PCT levels increase dramatically owing to the inflammatory response produced by bacterial endotoxins. Unlike viral infections that do not significantly influence the various level differentials between CRP and PCT, it makes PCT a more specific marker for bacterial infections [7]. This implies that high serum PCT concentration can indicate acute sepsis during the initiation phase whereas low serum PCT concentration could suggest late stages of sepsis. It has been observed that during any viral infection PCT level tends to remain stagnated it rises quickly at times with rapidity in response to bacterium invasion into the human body leading to its utilization as a distinguishing mark between these two types of infections Combines the use of CRP and PCT testing will enhance diagnostic accuracy both biomarkers have their strong points [8]. Two things can be seen here CRP’s general sensitivity towards inflammation whereas PCT works specifically against bacteria leading to an understanding of the underlying pathology [9]. Through these analyses, it has been observed that when it comes to inflammation detection CRP does help but PCT could differentiate whether an infection came from bacteria or virus thereby isolating particular conditions from others entirely redefining antibiotic prescriptions upon different acute respiratory diseases according to certain objectives including clinical decision support systems reducing inappropriate therapy prescriptions [10]. This study assesses the clinical use of PCT and CRP tests to distinguish specific viral and bacterial infections that cause ARDs. 1.2 Contributions The paper is categorized into Phrase 2 depicts related work, Phrase 3 describes the methodology, Phrase 4 has the evaluation findings, Phrase 5 explains the discussion, and Phrase 6 depicts the conclusion. Advances in multiplex polymerase chain reaction (PCR) and bacterial infection have been connected to the significance and burden of viral co-infections in pediatric acute respiratory illnesses [11]. The effects of these infectious diseases on the person infected and each other were investigated using identifications. Although viral-bacterial co-infections can raise morbidity because of their synergistic infecting of the nasopharyngeal area, they did not imply that viral-viral concurrent infections might enhance the burden of illness in pediatric patients. In a range of pediatric cases, the AutoPilot-Dx [12] validated the excellent diagnostic accuracy of a host-protein pattern including CRP and TNF-related apoptosis-induced ligand (TRAIL). With a 93.7% sensitivity, 94.2% specificity, 73.0% positive predictive value, and 98.9% negative prediction value, the characteristics were effectively identified between viral and bacterial infections. The outcomes showed that there can be a way to reduce the overuse of medications in children who have viral infections.